Clinical Nutrition for Cancer Care Market (By Product: Oral, Nutrition Enteral Feeding Formulas, Parenteral Nutrition; By Stage; By Sales Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

The global clinical nutrition for cancer care market size was estimated at around USD 5.66 billion in 2023 and it is projected to hit around USD 9.29 billion by 2033, growing at a CAGR of 5.08% from 2024 to 2033.

Key Pointers

• North America dominated the market with the largest market share 35% in 2023.
• By Product, the oral clinical nutrition held the largest revenue share of 45% in 2023.
• By Stage, the adults segment generated the maximum market share 81% in 2023.
• By Sales Channel, the institutional sales contributed the largest market share of 41% in 2023.

Clinical Nutrition for Cancer Care Market Overview

The clinical nutrition for cancer care market is witnessing significant growth as healthcare providers increasingly recognize the crucial role of nutrition in supporting cancer treatment outcomes.

Clinical Nutrition for Cancer Care Market Growth Factors

The growth of the clinical nutrition for cancer care market is driven by the rising prevalence of cancer worldwide is driving demand for specialized nutritional interventions to support patients throughout their treatment journey. Additionally, advancements in medical nutrition therapy and the development of innovative nutritional products tailored to the unique needs of cancer patients are contributing to market expansion. Moreover, increasing awareness among healthcare professionals about the critical role of nutrition in cancer care is leading to greater adoption of evidence-based nutrition interventions, further driving market growth. Furthermore, the growing trend towards personalized medicine and multidisciplinary approaches to cancer treatment is creating opportunities for the development of customized nutrition plans that can optimize treatment outcomes and improve patient quality of life.

Clinical Nutrition for Cancer Care Market Trends:

• Immunonutrition Advancements: The market is witnessing a surge in the development of immunonutrition solutions tailored to bolster the immune system of cancer patients, potentially enhancing treatment efficacy and reducing complications.
• Nutrigenomics Integration: Incorporating nutrigenomics into clinical nutrition approaches allows for personalized dietary recommendations based on an individual's genetic makeup, potentially optimizing treatment response and minimizing adverse effects.
• Multidisciplinary Care Models: There's a growing trend towards multidisciplinary cancer care models that integrate nutrition therapy seamlessly into comprehensive treatment plans, emphasizing the importance of collaboration among healthcare professionals to address patients' holistic needs.
• Targeted Nutrition Formulations: Manufacturers are increasingly focusing on developing specialized nutrition formulations targeting specific cancer types, treatment modalities, and patient populations, catering to the diverse nutritional requirements and challenges faced by individuals undergoing cancer treatment.
• Digital Health Solutions: The adoption of digital health technologies, such as mobile apps and telemedicine platforms, is facilitating remote monitoring of patients' nutritional status, enhancing communication between healthcare providers and patients, and enabling personalized nutrition support beyond traditional healthcare settings.
• Patient-Centric Approaches: There's a shift towards patient-centric approaches in cancer care, with greater emphasis on empowering patients to actively participate in managing their nutritional needs through education, self-monitoring tools, and access to supportive resources.

Product Insights

In 2023, oral clinical nutrition emerged as the dominant force in the market, commanding over 45% of the market share. These orally administered nutrition products specifically target cancer-related malnutrition, which stems from metabolic dysregulation and anorexia induced by both the tumor and its treatment. Their pivotal role lies in improving the quality of life for cancer patients by thwarting malnutrition, mitigating complications, and enhancing clinical outcomes. Additionally, these products are formulated to address common taste and smell alterations experienced by patients undergoing systemic antitumor therapy. Furthermore, their ease of consumption makes them highly suitable for patients who possess the ability to eat but face malnutrition or are at risk of it.

Looking ahead, the parenteral nutrition segment is poised for rapid growth during the forecast period. Parenteral nutrition assumes critical significance in cancer care due to the high prevalence of malnutrition among patients. Malnutrition not only leads to muscle depletion but also diminishes treatment response and overall quality of life. Hence, parenteral nutrition administers vital nutrients directly into the bloodstream, bypassing the digestive system. This method effectively slows down protein breakdown and reverses protein loss in organs, thereby potentially amplifying treatment outcomes.

Stage Insights

In 2023, adults dominated the segment, commanding over 81% of the market revenue share, and are projected to experience the most rapid growth throughout the forecast period. This trend is primarily driven by the prevalent occurrence of malnutrition among adult cancer patients. Clinical nutrition interventions have the potential to mitigate protein degradation and combat organ protein loss, ultimately leading to potential improvements in treatment outcomes. Furthermore, the implementation of clinical nutrition strategies is carefully tailored to each patient, taking into account their unique health circumstances and nutritional requirements.

According to the CDC, approximately 58% of cancer cases are diagnosed in adults aged 65 years or older. To address their specific nutritional needs, there has been a notable surge in the introduction of new oncology nutrition products. These products are specifically formulated to assist patients in managing diseases and coping with the side effects of treatment. Moreover, there is a growing recognition of the critical role of nutrition in cancer care, with increasing emphasis placed on its impact on patient health and well-being. This concerted effort includes the collaborative design of cancer nutrition care pathways, which is expected to further drive market growth.

Sales Channel Insights

In 2023, institutional sales emerged as the frontrunner in market revenue, commanding over 41% share. These institutions encompass government organizations, hospitals, and research institutes. With the escalating prevalence of cancer, there's a growing imperative for heightened nutritional support, precipitating a surge in clinical nutrition sales within hospital settings. Recent healthcare reforms have exerted pressure on hospitals to deliver cost-efficient, high-quality care, thereby fueling the demand for clinical nutrition products. Essentially, the robust demand for clinical nutrition for cancer care, combined with the expanding influence of hospitals and the intricacies of healthcare systems, elucidates why hospitals and institutional sales dominate clinical nutrition sales.

Meanwhile, the online sales segment is poised for the fastest growth over the forecast period. Advancements in telemedicine have facilitated the global dissemination of clinical nutrition products, enabling manufacturers to broaden their market outreach and cater to underserved communities. Consequently, online sales have experienced a notable upsurge owing to the mounting customer demand for medical foods tailored to address nutrition-based deficiencies in cancer patients.

Regional Insights

North America asserted its dominance in the market by capturing nearly 35% of the revenue share in 2023, and is poised to exhibit the fastest Compound Annual Growth Rate (CAGR) over the forecast period. Diseases such as esophageal cancer, gastric cancer, head & neck cancer, and laryngeal cancer often impede oral food intake in patients. The escalating prevalence of these conditions is anticipated to propel the demand for enteral and parenteral nutrition solutions in the region.

In 2023, Europe emerged as the second-largest regional market for clinical nutrition for cancer care. The region has proposed evidence-based recommendations concerning the organization of food catering, prescriptions, and indications of diets, as well as the monitoring of food intake at hospitals, rehabilitation centers, and nursing homes. The burgeoning healthcare expenditure in Europe is expected to drive technological advancements in the healthcare sector, thereby boosting the parenteral nutrition market in the region. Additionally, favorable reimbursement policies, increasing government investments in long-term healthcare, and enhancements in healthcare research infrastructure are anticipated to augment the utilization rates of parenteral nutrition over the next seven years.

Clinical Nutrition for Cancer Care Market Trends Key Companies

• Abbott Nutrition
• Pfizer Inc.
• Bayer AG
• Nestle Health Science S.A.
• GlaxoSmithKline plc
• Baxter International Inc.
• Otsuka Holdings Co., Ltd.
• Mead Johnson & Company, LLC
• Danone Nutricia
• Victus, Inc.

Recent Developments

• In March 2021, Kate Farms introduced two new products eligible for coverage under Medi-Cal insurance, targeting both children and adults. The products, Kate Farms Standard 1.4 in Vanilla and Plain flavors, along with Kate Farms Pediatric Peptide Vanilla Flavor 1.0, are designed to address nutrient deficiencies in patients coping with chronic diseases such as allergies, adult malnutrition, cancer, and gastrointestinal disorders.
• In September 2020, Baxter International Inc. obtained FDA approval for updated formulations of Clinimix and Clinimix E injections. These formulations aim to more efficiently meet patient protein targets while minimizing fluid and dextrose delivery.
• In April 2020, Esperer Onco Nutrition introduced Es-Fortitude and Es-Invigour, oral clinical nutrition supplements tailored for patients experiencing weight loss due to chemotherapy and other cancer treatments.

Clinical Nutrition for Cancer Care Market Segmentations:

By Product

• Oral Nutrition
• Parenteral Nutrition
• Enteral Feeding Formulas

By Stage

• Adult
• Pediatric

By Sales Channel

• Online
• Retail
• Institutional Sales

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)